Gulfo Adele M. (CIK 1647102) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-12). Recent activity: Buy NPO (567 shares), Buy NAMS (3,400 shares), Buy NAMS (10,860 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-12 | Enpro Inc. (NPO) | Director | Buy | 567 | $139,998 |
| 2026-01-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Director | Buy | 3,400 | $0 |
| 2025-04-17 | NewAmsterdam Pharma Co N.V. (NAMS) | Director | Buy | 10,860 | $0 |
Source: SEC Form 4 filings · as of 2026-02-12